“Looking for the very highest quality products and the consistency of a high-tech pharmaceuticals operation? Vida expects to file its licensing application before the end of April, a schedule that should allow it to have the necessary license in hand by the third quarter of this year. In the meantime, the company is raising $1.5 million at $.25 per share. That represents a market value of only $6 million for a company that now owns a 315,000-square-foot production plant with a replacement value estimated at $30 million. Personally, I think this will turn out to be an extraordinary investment. In less than a year’s time, this $.25 financing round is going to look extremely cheap.”
Related posts:
Michel Chossudovsky: US controlling both sides of Egypt coup
Runaway $168 million JLENS balloon downed by police shotgun blasts
Preposterous Waste, Pentagon Style
Law Professor Wants To Do Away With Most C's Because They Make Students Feel Bad
How Fascism Grows? Prison Company Buys Boca Stadium Naming Rights
Lavabit Owner Faces $10K Fine For Protecting Users From Federal Spying
'London Whale' Bruno Iksil Won't Be Prosecuted By Justice Department
Working Class Whites Are Giving Up Hope.
Terror Attacks And Terror Drills: A Series Of Strange Coincidences
Law enforcement uses smart meter parking apps to spy on everyone
Afghani Hornets Get Pissed After Soldiers Blow Up Their Home
What NSA Transparency Looks Like
Toughest encryption cracked by listening to your CPU with a phone
Michigan Small-Town Mayor Accepts Bitcoins For Re-Election Campaign
Anti-drone protests kick off in San Diego